Drug intelligence / Profile preview

acute intermittent hypoxia

Development stage
Phase 1
Lead developer
Emory University
Administration
Inhalation
01

Overview

Acute Intermittent Hypoxia (AIH) is a non-pharmacological therapeutic intervention being developed by researchers at Emory University for the treatment of spinal cord injury (SCI). The protocol involves brief, repeated exposures to low-oxygen gas mixtures (typically 9% oxygen) for 60-90 seconds, alternating with periods of normal room air (normoxia). This cyclic breathing pattern is designed to induce spinal plasticity by stimulating serotonergic neurons in the brainstem, leading to the release of serotonin near motor neurons. This trigger initiates a cellular cascade involving the synthesis of brain-derived neurotrophic factor (BDNF) and the activation of TrkB receptors, which ultimately strengthens spared neural pathways and enhances motor output. Clinical research at Emory has focused on using AIH to improve hand function, walking ability, and grip strength in patients with chronic incomplete cervical spinal cord injuries, often in combination with task-specific training.

Other names
AIHintermittent hypoxia
02

Targets

NTRK2 (Tropomyosin-related kinase receptor type B)

Beyond the preview

Go deeper on acute intermittent hypoxia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acute intermittent hypoxia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call